2026 Course Directors
The Lysosomal Disease Summit is guided by an international group of clinical and scientific leaders specialising in lysosomal and inherited metabolic disorders.
Michel Tchan, MBBS, PhD, BMedSc, FRACP
Head, Department of Genetic Medicine
Westmead Hospital
Associate Professor, University of Sydney
Sydney, Australia
Dr Michel Tchan is a clinical and metabolic geneticist specialising in adult inherited metabolic disorders. He leads the Department of Genetic Medicine at Westmead Hospital and holds an academic appointment at the University of Sydney. His clinical and research work focuses on the diagnosis and management of genetic metabolic disorders and improving care for adults with inherited conditions.
Professor Maria Fuller, BAppSc, MAppSc, PhD, FFSc (RCPA)
National Referral Laboratory – Genetics and Molecular Pathology
SA Pathology
Adelaide Medical School and School of Biological Sciences, University of Adelaide
Adelaide, Australia
Professor Maria Fuller is a clinical scientist specialising in biochemical genetics. She leads the National Referral Laboratory within the state-wide public pathology service in South Australia and holds a conjoint academic appointment at the University of Adelaide. Her work focuses on lysosomal storage disorders and inherited metabolic diseases, with contributions to more than 120 publications in the scientific and medical literature.
Uma Ramaswami, FRCPCH, MD
Consultant in Inherited Metabolic Disorders
Clinical Lead, Lysosomal Storage Disorders Unit
Royal Free London NHS Foundation Trust
Honorary Associate Professor, University College London
London, United Kingdom
Dr Uma Ramaswami is a consultant specialising in inherited metabolic disorders and lysosomal diseases. She leads the Lysosomal Storage Disorders Unit at the Royal Free Hospital in London and holds an honorary academic appointment at University College London. She has more than twenty years of clinical experience managing children and adults with inherited metabolic disorders. Her research focuses on the natural history, disease progression, and long-term management of lysosomal storage disorders.